• Lupin Irebesartan Recall Issued Over Cancer Causing N-nitrosoirbesartan Contamination

  October 15, 2021 By: Irvin Jackson

  Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.

• Generic Chantix Launched Following Recall of Name Brand Drug Due To Toxic Contaminant

  September 27, 2021 By: Irvin Jackson

  The first generic version of Chantix has been announced just days after a complete recall of the brand name smoking cessation drug.

• Pfizer Recalling All Chantix Batches Due to Carcinogen in Smoking Cessation Drug

  September 17, 2021 By: Irvin Jackson

  Pfizer has issued a full recall of all Chantix nationwide, due to the presence of potentially cancer-causing chemicals.

• Chantix Class Action Lawsuit Filed Over Cancer-Causing Impurity

  August 20, 2021 By: Irvin Jackson

  A recent Chantix recall has resulted in a class action lawsuit against Pfizer, which claims the company sold a defective drug to consumers which put them at an increased risk…

• More Chantix Recalled Due To Cancer-Causing Chemicals, As N-Nitroso Varenicline Found in Additional Lots

  August 18, 2021 By: Irvin Jackson

  Pfizer is recalling four additional lots of Chantix due to high levels of a potentially cancer-causing contaminant.

• Chantix Recall Expanded To U.S. Products Due To N-Nitroso Varenicline Contamination

  July 20, 2021 By: Irvin Jackson

  Pfizer is recalling 12 lots of Chantix due to excessive levels of N-nitroso-varenicline, which may cause cancer in humans.

• Pfizer Suspends Chantix Distribution Due to Presence of Cancer-Causing NDMA

  June 29, 2021 By: Irvin Jackson

  Pfizer has halted distribution of Chantix due to the potential presence of high levels of NDMA or other nitrosamines which could increase the risk of cancer.

• Little Known About Breaking Teens’ JUUL Addictions, FDA Told At Hearing

  January 22, 2019 By: Irvin Jackson

  Participants at a recent FDA hearing said there is little data on whether smoking cessation drugs like Chantix and Zyban would be useful in treating teen electronic cigarette addictions.

• Chantix, Zyban Heart Risks Questioned In New Study

  April 12, 2018 By: Irvin Jackson

  A new study appears to contradict previous findings indicating that Chantix and similar smoking cessation drugs carried an increased risk of heart problems.

• Chantix Heart Risks Highlighted in New Study

  December 22, 2017 By: Austin Kirk

  A new study warns that Chantix may increase the risk of heart problems, but carries low to no risk of neuropsychiatric side effects.